… This review summarizes current prognostic biomarkers and predictive biomarkers for ICIs
in … will respond to immune checkpoint inhibition. Other biomarkers mentioned in this review …

… biomarker is warranted. This review examines the available evidence on emerging immune
predictive biomarkers of response to … use as a predictive immune biomarker in this disease. …

… been explored as predictive biomarker of response to PD-1/PD-L1 inhibitors. The phase 2
Keynote-158 study showed a significantly improved response to pembrolizumab in multiple …

… response. This underscores the need to improve our understanding of the molecular determinants
of response to … Here, we describe available biomarkers of checkpoint blockade activity …

… checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with
sustained responses … and development of predictive biomarkers for the response of ICIs, and …

… established independent predictor of immune checkpoint inhibitor (ICPI) treatment outcome
… ICPIs by response rate and survival. TMB, alongside other genomic biomarkers, may provide …

… biomarkers of response to ICIs and address future direction on overcoming resistance to
immune checkpoint … Finally, we will describe emerging biomarkers of response to ICIs and …

… and the interaction of multiple elements is eventually required to define the best biomarkers
of response to checkpoint inhibitors. Ultimately identifying predictive biomarkers requires …

… , so to reliable biomarkers of responses to cancer immunotherapy. … for immune-related
biomarkers pertaining to Melanoma, Basal … checkpoint inhibitor therapy biomarker advancements. …

… Therefore, other biomarkers have … checkpoint inhibitor (ICI) therapy in general. Of those,
TMB has been extensively studied as an alternative or complementary biomarker for response to …